Overview

A Comparison of Crystalloid Alone Versus Crystalloid Plus Colloid in Shock Resuscitation

Status:
Unknown status
Trial end date:
2018-11-01
Target enrollment:
0
Participant gender:
All
Summary
Fluid resuscitation is the most effective treatment of shock. Isotonic crystalloid solution is the current recommended initial fluid resuscitation. However, this kind of fluid has high volume of distribution and may require large volume administration before achieve therapeutic goal of shock reversal. There are rising concern about the delay in shock reversal and adverse consequences of large amount volume of fluid therapy. Colloid fluid have been used as the alternate fluid resuscitation, aiming to limit the volume of fluid resuscitation and promote shock reversal. Whether colloid infusion can improve shock reversal rate and decrease complication associated with fluid resuscitation, had inconclusive information.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Mahidol University
Collaborator:
Siriraj Hospital
Treatments:
Pharmaceutical Solutions
Criteria
Inclusion Criteria:

- Age at least 18 years old

- New onset of shock within 24 hours

- Mean arterial blood pressure less than 65 mmHg or systolic blood pressure less than
60% of patient's baseline blood pressure

- Evidence of poor tissue perfusion including: urine output less than 0.5 mL/kg/hr,
lactate more than 2 mmol/L, alteration of consciousness without other explanation

- Evidence of fluid inadequacy (CVP < 12 mmHg, Pulmonary capillary wedge pressure < 18
mmHg) or evidence of fluid responsive (IVC diameter variation > 15%, pulse pressure
variation > 15%, positive fluid challenge test)

Exclusion Criteria:

- Prolong shock more than 24 hours

- Received colloid solution more than 1,000 mL in previous 72 hours

- Do not resuscitation documented patient

- Contraindication for fluid therapy including: suspected cardiogenic shock, evidence of
pulmonary edema, history of anaphylaxis after fluid therapy